About

Carole Fakhry is a leading head and neck surgeon and researcher whose work has fundamentally reshaped the understanding and management of human papillomavirus (HPV)-related oropharyngeal cancer. Her research focuses on the intersection of virology, surgical innovation, and cancer outcomes, particularly in HPV-positive squamous cell carcinoma of the head and neck. Fakhry’s landmark 2016 study (119 citations) demonstrated that HPV detection in unknown primary head and neck cancers directs the search for the primary tumor to the oropharynx, changing diagnostic protocols. She has been a pioneer in transoral robotic surgery (TORS), authoring influential papers on its clinical outcomes and the impact of surgical margins on local control in HPV-related disease (44 citations). Her work has also advanced minimally invasive techniques, including robotic-assisted neck dissection through cosmetically favorable incisions. Notably, Fakhry led the development of the 2025 ASCO Guideline on TORS in multidisciplinary care, cementing her role as a national authority. Her 2024 study revealing lower survival for HPV-related oropharynx cancer surgery at community centers highlights her commitment to equitable, high-quality care. With over 300 cumulative citations, Fakhry’s contributions continue to guide surgical practice and improve outcomes for patients with HPV-driven head and neck cancers.

Research Focus

Key Achievements

7
H-Index
8
Papers
337
Total Citations
42
Avg Citations/Paper
🏆 Most Cited Paper
Changes in Unknown Primary Squamous Cell Carcinoma of the Head and Neck at Initial Presentation in the Era of Human Papillomavirus
119 citations · 2016
📈 Most Prolific Year: 2012 (2 Papers)
🤝 Key Collaborators: 60
🏛 Institutions: Johns Hopkins Medicine, University of Maryland, Baltimore, Johns Hopkins University, Greater Baltimore Medical Center

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago